These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15919981)

  • 1. Cell biology. Lessons in rational drug design for protein kinases.
    Ahn NG; Resing KA
    Science; 2005 May; 308(5726):1266-7. PubMed ID: 15919981
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
    Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
    J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural bioinformatics-based design of selective, irreversible kinase inhibitors.
    Cohen MS; Zhang C; Shokat KM; Taunton J
    Science; 2005 May; 308(5726):1318-21. PubMed ID: 15919995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity.
    Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indole RSK inhibitors. Part 1: discovery and initial SAR.
    Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
    Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational design and discovery of conformationally flexible inhibitors of acetohydroxyacid synthase to overcome drug resistance associated with the W586L mutation.
    Ji FQ; Niu CW; Chen CN; Chen Q; Yang GF; Xi Z; Zhan CG
    ChemMedChem; 2008 Aug; 3(8):1203-6. PubMed ID: 18478622
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible covalent inhibition of a protein target.
    Lee CU; Grossmann TN
    Angew Chem Int Ed Engl; 2012 Aug; 51(35):8699-700. PubMed ID: 22806944
    [No Abstract]   [Full Text] [Related]  

  • 8. SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration.
    Lu W; Liu X; Cao X; Xue M; Liu K; Zhao Z; Shen X; Jiang H; Xu Y; Huang J; Li H
    J Med Chem; 2011 May; 54(10):3564-74. PubMed ID: 21488662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 3: Importance of the indole orientation.
    Lu Q; Chen Z; Perumattam J; Wang DX; Liang W; Xu YJ; Do S; Bonaga L; Higaki J; Dong H; Liclican A; Sideris S; Laney M; Dugar S; Mavunkel B; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2399-403. PubMed ID: 18337095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrimidine-based inhibitors of CaMKIIdelta.
    Mavunkel B; Xu YJ; Goyal B; Lim D; Lu Q; Chen Z; Wang DX; Higaki J; Chakraborty I; Liclican A; Sideris S; Laney M; Delling U; Catalano R; Higgins LS; Wang H; Wang J; Feng Y; Dugar S; Levy DE
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2404-8. PubMed ID: 18334293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization.
    Terasaka T; Kinoshita T; Kuno M; Nakanishi I
    J Am Chem Soc; 2004 Jan; 126(1):34-5. PubMed ID: 14709046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double trouble.
    Miller WT
    Nat Struct Biol; 2001 Jan; 8(1):16-8. PubMed ID: 11135660
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
    Furet P; Schoepfer J; Radimerski T; Chène P
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4014-7. PubMed ID: 19560355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AKT crystal structure and AKT-specific inhibitors.
    Kumar CC; Madison V
    Oncogene; 2005 Nov; 24(50):7493-501. PubMed ID: 16288296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisubstrate adduct inhibitors: drug design and biological tools.
    Le Calvez PB; Scott CJ; Migaud ME
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1291-318. PubMed ID: 19912064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 2: SAR of the amine tether.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Higaki J; Dong H; Liclican A; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2395-8. PubMed ID: 18334295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography.
    Englebienne P; Fiaux H; Kuntz DA; Corbeil CR; Gerber-Lemaire S; Rose DR; Moitessier N
    Proteins; 2007 Oct; 69(1):160-76. PubMed ID: 17557336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.